Gait and Balance Disorders in Progressive Supranuclear Palsy

Gait and Balance Disorders in Progressive Supranuclear Palsy

Overview

Gait and balance impairments are the defining clinical features of Progressive Supranuclear Palsy (PSP), often presenting as the initial symptoms and contributing to the characteristic progressive postural instability that defines the disease[@litvan1996]. Unlike Parkinson's disease where gait disturbances typically begin asymmetrically and respond to dopaminergic therapy, PSP gait disorders are characterized by early, symmetric postural instability with a broad-based gait pattern and prominent freezing phenomena[@fahn2003]. The neural substrate for these deficits lies in the degeneration of key brainstem and subcortical structures including the pedunculopontine nucleus, vestibular nuclei, superior colliculus, and basal ganglia output nuclei[@karachi2010].

This page provides a comprehensive synthesis of the evidence regarding gait and balance dysfunction in PSP, covering pathophysiology, clinical manifestations, assessment tools, and therapeutic interventions. Particular attention is given to the distinction from Parkinson's disease and other atypical parkinsonisms, as accurate characterization is essential for diagnosis and management.

Pathophysiology of Gait and Balance Impairment

Neuroanatomical Substrates

The gait and balance deficits in PSP arise from a distinctive pattern of neurodegeneration affecting multiple neural systems that collectively regulate posture, locomotion, and vestibular function:

Gait and Balance Disorders in Progressive Supranuclear Palsy

Overview

Gait and balance impairments are the defining clinical features of Progressive Supranuclear Palsy (PSP), often presenting as the initial symptoms and contributing to the characteristic progressive postural instability that defines the disease[@litvan1996]. Unlike Parkinson's disease where gait disturbances typically begin asymmetrically and respond to dopaminergic therapy, PSP gait disorders are characterized by early, symmetric postural instability with a broad-based gait pattern and prominent freezing phenomena[@fahn2003]. The neural substrate for these deficits lies in the degeneration of key brainstem and subcortical structures including the pedunculopontine nucleus, vestibular nuclei, superior colliculus, and basal ganglia output nuclei[@karachi2010].

This page provides a comprehensive synthesis of the evidence regarding gait and balance dysfunction in PSP, covering pathophysiology, clinical manifestations, assessment tools, and therapeutic interventions. Particular attention is given to the distinction from Parkinson's disease and other atypical parkinsonisms, as accurate characterization is essential for diagnosis and management.

Pathophysiology of Gait and Balance Impairment

Neuroanatomical Substrates

The gait and balance deficits in PSP arise from a distinctive pattern of neurodegeneration affecting multiple neural systems that collectively regulate posture, locomotion, and vestibular function:

The pedunculopontine nucleus (PPN), a critical node in the reticular formation that regulates locomotion and arousal, shows severe tau pathology in PSP [@jellinger2019]. Degeneration of cholinergic neurons in the PPN correlates with freezing of gait and falls, as this structure provides descending commands to spinal locomotor circuits and receives integration from basal ganglia output [@theodosis2020]. The PPN also maintains connections with the vestibular nuclei in the brainstem, which process information about head position and movement through the vestibular apparatus [@lacour2019].

Vestibular System Dysfunction

The vestibular nuclei — particularly the medial and superior vestibular nuclei — receive extensive input from the vestibular nerve and project to the spinal cord via the vestibulospinal tracts to control postural tone. In PSP, tau pathology affects these nuclei directly and indirectly through disruption of the nodulus and uvula of the vestibulocerebellum, leading to impaired postural reflexes and reduced ability to recover from perturbations [@brandt2005]. This vestibular dysfunction manifests clinically as a propensity to fall backward (retropulsion), which is a cardinal feature distinguishing PSP from Parkinson's disease [@ondo2001].

The superior colliculus plays a important role in orienting responses and integrating visual, auditory, and somatosensory information for postural control. Tau pathology in the intermediate and deep layers of the superior colliculus contributes to the characteristic supranuclear gaze palsy and may also impair the visual fixation mechanisms necessary for stable ambulation [@bhattacharya2002].

Clinical Manifestations

Postural Instability

Postural instability in PSP is among the most disabling symptoms, typically appearing within the first year of disease onset and progressing relentlessly. The Pull Test — a standard assessment of postural stability — reveals marked retropulsion, with patients requiring multiple corrective steps or falling when gently pulled backward [@postural2003]. Unlike PD, where postural instability typically develops late and after years of disease, early postural failure in PSP reflects the widespread brainstem pathology that characterizes the disease.

The sway characteristics in PSP differ quantitatively from other parkinsonisms. Studies using posturography demonstrate increased sway area and velocity, particularly in the anteroposterior direction, even when patients stand with feet together. This reflects impaired integration of somatosensory, vestibular, and visual inputs for postural control [@rocchi2020]. The loss of vestibular function also contributes to difficulty walking on uneven surfaces and in low-light conditions.

Freezing of Gait

Freezing of gait (FOG) occurs in approximately 50-70% of PSP patients and is often more severe and earlier in onset than in Parkinson's disease [@factor2017]. PSP-FOG is characterized by sudden, transient episodes where patients feel their feet are "glued to the floor," typically triggered by:

• Initiating walking (start hesitation)
• Turning (turn hesitation)
• Approaching obstacles or doorways
• Narrowing of gait path
• Dual-tasking

Gait Aprexia

A distinctive feature of PSP is gait aprexia — a failure of the voluntary motor programs necessary for ambulation despite relatively preserved strength and coordination [@atchison2004]. Patients exhibit:

• Difficulty initiating gait
• Shuffling with small steps
• Incomplete foot clearance ("magnetic gait")
• Reduced arm swing (may be symmetric)
• Freezing when approaching obstacles

Falls and Injury

Falls are nearly universal in PSP, with retrospective studies indicating that 70-90% of patients experience at least one fall by the third year of disease [@bloem2004]. The falls in PSP are characterized by:

• Direction: Primarily backward (retropulsion) or sideways
• Circumstances: Turning, standing up, walking on uneven ground
• Consequences: Higher fracture rates than PD, particularly hip and wrist fractures
• Predictors: Disease severity, postural instability score, FOG severity

Fall Prediction and Risk Assessment

Clinical Prediction Tools

Multiple clinical instruments have been validated for predicting falls in PSP:

| Assessment Tool | Description | Fall Prediction Value |
|----------------|-------------|---------------------|
| Pull Test Score | 0-3 scale of retropulsion | Strong predictor of future falls |
| BBS (Berg Balance Scale) | 14-item functional balance test | <40 predicts high fall risk |
| Tinetti Mobility Index | Gait and balance assessment | <19 indicates high risk |
| PSP Rating Scale | Disease-specific severity scale | Higher scores correlate with falls |
| Frontal Assessment Battery | Executive function testing | Lower scores predict falls |

The BBS cutoff of <40 has demonstrated excellent sensitivity for identifying PSP patients at high risk of falls, while the Tinetti mobility index provides prognostic information regarding injury risk [@berg1992].

Quantitative Measures

Instrumented gait analysis provides objective measures that correlate with fall risk:

• Gait velocity: <0.5 m/s indicates high fall risk
• Stride length variability: Higher variability predicts falls
• Double support time: Prolonged double support indicates insecurity
• Sway during standing: Increased sway area predicts future falls

Fall Prevention Strategies

Environmental Modifications

Environmental interventions form the foundation of fall prevention:

• Home safety assessment: Remove throw rugs, install grab bars in bathroom, improve lighting
• Footwear: Firm, flat shoes with good traction; avoid slippers
• Assistive devices: Walking sticks, walkers, wheelchairs for advanced disease
• Bed positioning: Lower bed height to reduce injury if falls occur at night

Pharmacological Approaches

Pharmacological management of fall risk in PSP is limited by the underlying neurodegeneration:

• Levodopa: Modest improvement in some patients, but less effective than in PD
• Clonazepam: May reduce FOG in some patients, but increases fall risk from sedation
• Donepezil: Cholinergic enhancement shows promise in small studies for PPN-related dysfunction [@srivastava2007]
• Aminopyridines: Potassium channel blockers may improve vestibular function

Assistive Devices

Walking Aids

Selection of assistive devices should match the patient's specific deficits:

• Cane/walking stick: Suitable for mild postural instability; provides tactile feedback
• Standard walker: For moderate impairment; requires adequate upper body strength
• Wheeled walker: Recommended for PSP due to frequent retropulsion; allows steady support
• Wheelchair: Required for advanced disease; consider powered option

Orthotic Devices

• Ankle-foot orthoses: May improve foot clearance during swing phase
• Hip protectors: Reduce fracture risk in frequent fallers
• Weighted vests: Provide proprioceptive feedback that may improve stability

Rehabilitation Strategies

Physical Therapy

Targeted physical therapy interventions for PSP include:

Evidence from small trials suggests that intensive, task-specific training may temporarily improve gait velocity and reduce fall frequency in PSP, though benefits are not disease-modifying [@saleem2020].

Vestibular Rehabilitation

Given the significant vestibular dysfunction in PSP, vestibular rehabilitation may be beneficial:

• Habituation exercises for dizzy symptoms
• Balance retraining with sensory reweighting
• Gaze stabilization exercises (though limited by gaze palsy)
• Adaptation exercises using residual vestibular function

Occupational Therapy

Occupational therapists provide:

• Activity of daily living training
• Home modification recommendations
• Energy conservation techniques
• Caregiver education

Speech and Swallowing

While primarily focused on speech, speech therapists also address:

• Safe swallowing techniques to prevent aspiration
• Vocal Loudness therapy (Lee Silverman Voice Treatment) adapted for PSP
• Respiratory muscle training

Cross-System Interactions

Autonomic Dysfunction and Gait

The autonomic dysfunction common in PSP ([see: Autonomic Dysfunction in Progressive Supranuclear Palsy](/mechanisms/psp-autonomic-dysfunction)) directly impacts gait and balance through multiple mechanisms [@wenning2013]:

• Orthostatic hypotension causes cerebral hypoperfusion during standing, leading to dizziness and falls
• Bladder dysfunction creates urgency that may precipitate falls during bathroom trips
• Thermoregulatory dysfunction can cause hypotension and weakness

Sleep Disorders and Gait

Sleep disorders in PSP ([see: Sleep and Circadian Disorders in Progressive Supranuclear Palsy](/mechanisms/psp-sleep-circadian-disorders)) contribute to daytime dysfunction and fall risk [@arnulf2015]:

• REM sleep behavior disorder can cause violent movements during sleep, leading to falls upon awakening
• Sleep fragmentation from nocturnal akinesia reduces daytime alertness
• Circadian disruption may affect postural control mechanisms

Differential Diagnosis

Parkinson's Disease

| Feature | PSP | Parkinson's Disease |
|---------|-----|-------------------|
| Postural instability | Early (within 1 year) | Late (after 5+ years) |
| Gait | Broad-based, shuffling | Shuffling, narrow-based |
| Freezing | Early, severe | Variable, later |
| Falls | Early, frequent | Late, less frequent |
| Response to levodopa | Poor | Good initially |
| Symmetry | Symmetric early | Asymmetric |

Multiple System Atrophy

• MSA-P may present with similar parkinsonism but typically shows:
• Earlier autonomic failure
• Cerebellar signs in MSA-C
• Imaging findings (hot cross bun sign)
• More levodopa responsiveness initially

Corticobasal Degeneration

• Asymmetric onset
• Apraxia of the affected limb
• Alien limb phenomenon
• Cortical sensory loss

Management Algorithm

Evidence Summary

Key Studies

Conclusion

Gait and balance disorders in PSP arise from the distinctive pattern of brainstem and subcortical tau pathology that characterizes the disease. The combination of postural instability, freezing of gait, and gait aprexia creates a uniquely disabling syndrome that differs qualitatively from other parkinsonisms. Management requires a comprehensive, multidisciplinary approach incorporating fall risk assessment, environmental modifications, assistive devices, targeted rehabilitation, and integration with autonomic and sleep disorder management. While current interventions cannot halt disease progression, optimized symptomatic management can significantly reduce fall risk and improve quality of life.

See Also

• [Autonomic Dysfunction in Progressive Supranuclear Palsy](/mechanisms/psp-autonomic-dysfunction)
• [Sleep and Circadian Disorders in Progressive Supranuclear Palsy](/mechanisms/psp-sleep-circadian-disorders)
• [Progressive Supranuclear Palsy (PSP) Pathway](/mechanisms/psp-pathway)
• [Pedunculopontine Nucleus in Gait and Arousal](/cell-types/pedunculopontine-nucleus-gait)
• [Vestibular Nuclei in Balance](/cell-types/vestibular-nuclei-balance)
• [Pure Akinesia with Gait Freezing](/diseases/pure-akinesia-gait-freezing)

References